Literature DB >> 27911827

Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.

Amanda L Woerman1,2, Atsushi Aoyagi1,3, Smita Patel1, Sabeen A Kazmi1, Iryna Lobach4, Lea T Grinberg2,5, Ann C McKee6,7,8,9,10, William W Seeley2,5, Steven H Olson1,2, Stanley B Prusiner11,2,12.   

Abstract

Tau prions are thought to aggregate in the central nervous system, resulting in neurodegeneration. Among the tauopathies, Alzheimer's disease (AD) is the most common, whereas argyrophilic grain disease (AGD), corticobasal degeneration (CBD), chronic traumatic encephalopathy (CTE), Pick's disease (PiD), and progressive supranuclear palsy (PSP) are less prevalent. Brain extracts from deceased individuals with PiD, a neurodegenerative disorder characterized by three-repeat (3R) tau prions, were used to infect HEK293T cells expressing 3R tau fused to yellow fluorescent protein (YFP). Extracts from AGD, CBD, and PSP patient samples, which contain four-repeat (4R) tau prions, were transmitted to HEK293 cells expressing 4R tau fused to YFP. These studies demonstrated that prion propagation in HEK cells requires isoform pairing between the infecting prion and the recipient substrate. Interestingly, tau aggregates in AD and CTE, containing both 3R and 4R isoforms, were unable to robustly infect either 3R- or 4R-expressing cells. However, AD and CTE prions were able to replicate in HEK293T cells expressing both 3R and 4R tau. Unexpectedly, increasing the level of 4R isoform expression alone supported the propagation of both AD and CTE prions. These results allowed us to determine the levels of tau prions in AD and CTE brain extracts.

Entities:  

Keywords:  Pick’s disease; argyrophilic grain disease; corticobasal degeneration; progressive supranuclear palsy; tauopathies

Mesh:

Substances:

Year:  2016        PMID: 27911827      PMCID: PMC5167200          DOI: 10.1073/pnas.1616344113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

3.  Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease.

Authors:  M L Schmidt; V Zhukareva; K L Newell; V M Lee; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  2001-05       Impact factor: 17.088

4.  Characterisation of interface astroglial scarring in the human brain after blast exposure: a post-mortem case series.

Authors:  Sharon Baughman Shively; Iren Horkayne-Szakaly; Robert V Jones; James P Kelly; Regina C Armstrong; Daniel P Perl
Journal:  Lancet Neurol       Date:  2016-06-09       Impact factor: 44.182

5.  Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team.

Authors:  Heidi Terrio; Lisa A Brenner; Brian J Ivins; John M Cho; Katherine Helmick; Karen Schwab; Katherine Scally; Rick Bretthauer; Deborah Warden
Journal:  J Head Trauma Rehabil       Date:  2009 Jan-Feb       Impact factor: 2.710

Review 6.  Biology and genetics of prions causing neurodegeneration.

Authors:  Stanley B Prusiner
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

7.  Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.

Authors:  S Flament; A Delacourte; M Verny; J J Hauw; F Javoy-Agid
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

9.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

Review 10.  Characteristics of Tau and Its Ligands in PET Imaging.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Tetsuro Tago; Kazuhiko Yanai; Hiroyuki Arai; Yukitsuka Kudo
Journal:  Biomolecules       Date:  2016-01-06
View more
  63 in total

1.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

2.  Cofactors are essential constituents of stable and seeding-active tau fibrils.

Authors:  Yann Fichou; Yanxian Lin; Jennifer N Rauch; Michael Vigers; Zhikai Zeng; Madhur Srivastava; Timothy J Keller; Jack H Freed; Kenneth S Kosik; Songi Han
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-11       Impact factor: 11.205

3.  Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity.

Authors:  Jean-Marc M Grandjean; Alexander Y Jiu; John W West; Atsushi Aoyagi; Daniel G Droege; Manuel Elepano; Makoto Hirasawa; Masakazu Hirouchi; Ryo Murakami; Joanne Lee; Koji Sasaki; Shimpei Hirano; Takao Ohyama; Benjamin C Tang; Roy J Vaz; Masahiro Inoue; Steven H Olson; Stanley B Prusiner; Jay Conrad; Nick A Paras
Journal:  ACS Med Chem Lett       Date:  2020-01-30       Impact factor: 4.345

4.  Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Authors:  Atsushi Aoyagi; Carlo Condello; Jan Stöhr; Weizhou Yue; Brianna M Rivera; Joanne C Lee; Amanda L Woerman; Glenda Halliday; Sjoerd van Duinen; Martin Ingelsson; Lars Lannfelt; Caroline Graff; Thomas D Bird; C Dirk Keene; William W Seeley; William F DeGrado; Stanley B Prusiner
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

5.  Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?"

Authors:  Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2018-10-03

Review 6.  Prion-like Spreading in Tauopathies.

Authors:  Jacob I Ayers; Benoit I Giasson; David R Borchelt
Journal:  Biol Psychiatry       Date:  2017-04-13       Impact factor: 13.382

7.  Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.

Authors:  Paul Matthew Seidler; David R Boyer; Kevin A Murray; Tianxiao P Yang; Megan Bentzel; Michael R Sawaya; Gregory Rosenberg; Duilio Cascio; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; David S Eisenberg
Journal:  J Biol Chem       Date:  2019-09-19       Impact factor: 5.157

Review 8.  Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Virginia M-Y Lee
Journal:  Neurobiol Dis       Date:  2017-07-24       Impact factor: 5.996

9.  Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.

Authors:  Noah R Johnson; Carlo Condello; Shenheng Guan; Abby Oehler; Julia Becker; Marta Gavidia; George A Carlson; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

10.  Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model.

Authors:  Chad A Tagge; Andrew M Fisher; Olga V Minaeva; Amanda Gaudreau-Balderrama; Juliet A Moncaster; Xiao-Lei Zhang; Mark W Wojnarowicz; Noel Casey; Haiyan Lu; Olga N Kokiko-Cochran; Sudad Saman; Maria Ericsson; Kristen D Onos; Ronel Veksler; Vladimir V Senatorov; Asami Kondo; Xiao Z Zhou; Omid Miry; Linnea R Vose; Katisha R Gopaul; Chirag Upreti; Christopher J Nowinski; Robert C Cantu; Victor E Alvarez; Audrey M Hildebrandt; Erich S Franz; Janusz Konrad; James A Hamilton; Ning Hua; Yorghos Tripodis; Andrew T Anderson; Gareth R Howell; Daniela Kaufer; Garth F Hall; Kun P Lu; Richard M Ransohoff; Robin O Cleveland; Neil W Kowall; Thor D Stein; Bruce T Lamb; Bertrand R Huber; William C Moss; Alon Friedman; Patric K Stanton; Ann C McKee; Lee E Goldstein
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.